Stay updated on Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial
Sign up to get notified when there's something new on the Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial page.

Latest updates to the Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision: v3.6.6 appears, replacing v3.6.5; this denotes a page version update rather than substantive content changes to the study details.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe study details page updated to revision v3.6.5. Sponsor attribution and some helper-link sections were removed, changing how the sponsor information and navigation are presented.SummaryDifference0.1%

- Check54 days agoChange DetectedNew sections More Information and Helpful Links Provided by Naurex, Inc, an affiliate of Allergan plc have been added, and the revision notice was updated from v3.6.3 to v3.6.4.SummaryDifference0.1%

- Check61 days agoChange DetectedRemoved sponsor attribution and footer help sections from the study page. This includes the Naurex, Inc, an affiliate of Allergan plc sponsor line and the 'More Information' and 'Helpful Links Provided by' areas.SummaryDifference0.1%

- Check75 days agoChange DetectedFooter/meta area updated to include More Information, Naurex, Inc., an affiliate of Allergan plc, and Helpful Links Provided by Naurex. The page revision tag was updated from v3.6.1 to v3.6.3.SummaryDifference0.1%

- Check82 days agoChange DetectedRevision label on the page was updated from v3.6.0 to v3.6.1, indicating a minor update to the page metadata.SummaryDifference0.0%

Stay in the know with updates to Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial page.